These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 38275816)

  • 1. Regulating Androgen Receptor Function in Prostate Cancer: Exploring the Diversity of Post-Translational Modifications.
    Lumahan LEV; Arif M; Whitener AE; Yi P
    Cells; 2024 Jan; 13(2):. PubMed ID: 38275816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranslational modification of the androgen receptor in prostate cancer.
    van der Steen T; Tindall DJ; Huang H
    Int J Mol Sci; 2013 Jul; 14(7):14833-59. PubMed ID: 23863692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen action in the prostate gland.
    Yadav N; Heemers HV
    Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the androgen receptor by post-translational modifications.
    Coffey K; Robson CN
    J Endocrinol; 2012 Nov; 215(2):221-37. PubMed ID: 22872761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysine Acetyltransferases and Their Role in AR Signaling and Prostate Cancer.
    Jaiswal B; Agarwal A; Gupta A
    Front Endocrinol (Lausanne); 2022; 13():886594. PubMed ID: 36060957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-translational modification of the androgen receptor.
    Gioeli D; Paschal BM
    Mol Cell Endocrinol; 2012 Apr; 352(1-2):70-8. PubMed ID: 21820033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-translational modifications of nuclear receptors and human disease.
    Anbalagan M; Huderson B; Murphy L; Rowan BG
    Nucl Recept Signal; 2012; 10():e001. PubMed ID: 22438791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central role of SUMOylation in the regulation of chromatin interactions and transcriptional outputs of the androgen receptor in prostate cancer cells.
    Launonen KM; Varis V; Aaltonen N; Niskanen EA; Varjosalo M; Paakinaho V; Palvimo JJ
    Nucleic Acids Res; 2024 Sep; 52(16):9519-9535. PubMed ID: 39106160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathogenesis and progression of prostate cancer.
    Schrecengost R; Knudsen KE
    Semin Oncol; 2013 Jun; 40(3):244-58. PubMed ID: 23806491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of androgen-induced regulator ARD1 inhibits androgen receptor acetylation and prostate tumorigenesis.
    Wang Z; Wang Z; Guo J; Li Y; Bavarva JH; Qian C; Brahimi-Horn MC; Tan D; Liu W
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3053-8. PubMed ID: 22315407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines.
    Marques RB; Dits NF; Erkens-Schulze S; van Ijcken WF; van Weerden WM; Jenster G
    PLoS One; 2011; 6(8):e23144. PubMed ID: 21829708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling.
    Correa RG; Krajewska M; Ware CF; Gerlic M; Reed JC
    Oncotarget; 2014 Mar; 5(6):1666-82. PubMed ID: 24681825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells.
    Kaikkonen S; Jääskeläinen T; Karvonen U; Rytinki MM; Makkonen H; Gioeli D; Paschal BM; Palvimo JJ
    Mol Endocrinol; 2009 Mar; 23(3):292-307. PubMed ID: 19116244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative analysis of AR-mediated transcriptional regulatory network reveals IRF1 as an inhibitor of prostate cancer progression.
    Cheng Y; Wang D; Jiang J; Huang W; Li D; Luo J; Gu W; Mo W; Wang C; Li Y; Gu S; Xu Y
    Prostate; 2020 May; 80(8):640-652. PubMed ID: 32282098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3.
    Li N; Truong S; Nouri M; Moore J; Al Nakouzi N; Lubik AA; Buttyan R
    Oncogene; 2018 Apr; 37(17):2313-2325. PubMed ID: 29429990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen.
    Whitworth H; Bhadel S; Ivey M; Conaway M; Spencer A; Hernan R; Holemon H; Gioeli D
    PLoS One; 2012; 7(6):e38950. PubMed ID: 22761715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
    Wang Y; Romigh T; He X; Orloff MS; Silverman RH; Heston WD; Eng C
    Hum Mol Genet; 2010 Nov; 19(22):4319-29. PubMed ID: 20729295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen attenuates the inactivating phospho-Ser-127 modification of yes-associated protein 1 (YAP1) and promotes YAP1 nuclear abundance and activity.
    Cinar B; Al-Mathkour MM; Khan SA; Moreno CS
    J Biol Chem; 2020 Jun; 295(25):8550-8559. PubMed ID: 32376689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity.
    Chen C; Shao R; Li B; Zhai Y; Wang T; Li X; Miao L; Huang J; Liu R; Liu E; Zhu Y; Gao X; Zhang H; Wang Y
    Phytomedicine; 2021 May; 85():153514. PubMed ID: 33676083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.